Fingerprint
Dive into the research topics of 'Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically